Impact of Pharmacy-Led Dyslipidemia Interventions on Medication Safety and Therapeutic Failure in Patients

Abstract

The researchers sought to assess the impact of pharmacologic intervention on previously identified patients with coronary heart disease (CHD), diabetes, or multiple risk factors who experienced therapeutic failure in treating hyperlipidemia. The study also sought to evaluate changes in medication usage patterns, including rates of unsafe combination therapies before versus after the interventions, and reevaluate the analyses of barriers to effective treatment, including safety concerns.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2005
Accession Number
ADA433714

Entities

People

  • Heidi R. Snow
  • Joseph G. Weaver
  • Judy E. Mcmanus
  • Rhonda B. Mangione
  • Stacie K. Hackworth
  • Tammy Leung

Organizations

  • United States Agency for Healthcare Research and Quality

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Air Force
  • Air Force Facilities
  • Combination Therapy
  • Communication Systems
  • Data Analysis
  • Department Of Defense
  • Education
  • Health Care
  • Health Services
  • Heart Diseases
  • Intervention
  • Medical Personnel
  • Patient Education
  • Pharmacies
  • Risk Factors
  • Statins
  • Therapy

Fields of Study

  • Medicine

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.